Bringing the fundamentals into focus…
Back to Foghorn Therapeutics Inc.
How Foghorn Therapeutics Inc. stacks up
FHTX · against 126 other Healthcare companies of similar size
Overall
32/ 100
Near the bottom of its peers.
Ranked #95 of 127 · scores higher than 25% of peers
Bars: peers in each 10-point band of the overall score32 peers with an overall score of 30–39, including FHTX · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around FHTX| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 592M ILS (≈$160M) | 84 | 99 | 99 | 96 | 1 / 2 | |
| 2 | 356M AUD (≈$235M) | 81 | 98 | 35 | 97 | 0 / 2 | |
| 3 | 1.3B BRL (≈$238M) | 77 | 96 | 72 | 89 | 1 / 2 | |
| 4 | 178.5B KRW (≈$129M) | 76 | 91 | 55 | 77 | 0 / 2 | |
| 4 | 6.5B TWD (≈$200M) | 76 | 83 | 78 | 56 | 0 / 2 | |
| 87 | 223M USD | 34 | 8 | 4 | 28 | 0 / 2 | |
| 87 | 172M USD | 34 | 8 | 96 | 27 | 2 / 2 | |
| 93 | 221M USD | 33 | 8 | 62 | 28 | 2 / 2 | |
| 93 | 184M USD | 33 | 33 | 4 | 3 | 0 / 2 | |
| 95 | 126M USD | 32 | 33 | 84 | 10 | 2 / 2 | |
| 95 | 139M USD | 32 | 8 | 55 | 15 | 1 / 2 | |
| 97 | 222M USD | 31 | 8 | 84 | 20 | 2 / 2 | |
| 97 | 363M AUD (≈$240M) | 31 | 43 | — | 43 | 2 / 2 | |
| 97 | 107M USD | 31 | 75 | — | 15 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score